Therefore, it is manifested that CDK4 inhibition by palbociclib treatment alleviates the survival and proliferation of chondrosarcoma cells via the enhanced promotion of cell apoptosis by G1 cell cycle arrest. This evidence concerns the gene CDK4 and chondrosarcoma.